Summary
A case of post-anoxic action myoclonus is reported in which a very good control of the myoclonic jerks was achieved with levodopa, gaba and bacoflen, while the antiepileptic drugs did not seem to be useful.
Zusammenfassung
Beschrieben wird ein Fall von postanoxicher Myoklonie, der durch L-Dopa, Gaba und Bacoflen fast völlig unter Kontrolle gebracht werden konnte. Antiepileptische Medikamente scheinen nicht wirksam zu sein.
References
Boudouresques, J., Roger, J., Khalil, R., Vigouroux, R. A., Gosset, A., Pellissier, J. F., Tassinari, C. A.: A propos de 2 observations de syndrome de Lance et Adams. Effet therapeutique du RO-05-4023. Revue Neurol. 125, 306–309 (1971)
Castaigne, P., Cambier, J., Escourolle, R., Cathala, H. P., Lecasble, R.: Observation anatomo-clinique d'un syndrome myoclonique post-anoxique. Revue Neurol. 111, 60–73 (1964)
Castaigne, P., Cambier, J., Escourolle, R.: Les myoclonies d'intention et d'action. Revue Neurol. 111, 107–120 (1968)
Cartlidge, F., Hudgson, P., Weightman, D.: A comparation of bacoflen and diazepam in the treatment of spasticity. J. Neurol. Sci. 23, 17–24 (1974)
Chadwick, D., Hallet, M., Harris, R., Jenner, P., Reynolds, E. H., Marsden, C. D.: Manipulation of brain serotonin in the treatment of myoclonus. Lancet 1975 II, 424–425
Chadwick, D., Hallet, M., Harris, R., Jenner, P., Reynolds, E. H., Marsden, C. D.: Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hidroxytryptophan, triptophan with a monoamine oxidase inhibitor and clonazepam. Brain 100, 455–487 (1977)
Davidoff, R. A., Sears, E. S.: The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology (Minneap) 24, 957–963 (1974)
De Lean, J.: Action myoclonus and serotoninergic activity. N. Engl. J. Med. 296, 24, 1414–1415 (1977)
Goldberg, M. A., Dorman, J. D.: Intention myoclonus: successful treatment with clonazepam. Neurology (Minneap) 26, 24–26 (1976)
Lance, J. W., Adams, R. D.: The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopaty. Brain 86, 111–136 (1963)
Lhermitte, F., Talairach, J., Buser, P., Gautier, J. C., Bancaud, J., Gras, R., Truelle, J. L.: Myoclonies d'intention et d'action post-anoxiques. Etude stereotaxique et descruction du noyau ventral lateral du thalamus. Revue Neurol. 124, 5–20 (1971)
Lhermitte, F., Marteau, R., Degos, C. F.: Analyse pharmacologique d'un noveau cas de myoclonies d'intention et d'action post-anoxiques. Revue Neurol. 126, 107–114 (1972)
Minoli, G., Tredici, G.: Levodopa in treatment of myoclonus. Lancet 1974 II, 472
Rollinson, R. D., Gilligan, B. S.: Post-anoxic action myoclonus (Lance Adams Syndrome) responding to valproate. Arch. Neurol. 36, 44–45 (1979)
Sherwin, I., Redmon, W.: Successful treatment in action myoclonus. Neurology (Minneap) 19, 846–850 (1969)
Van Woert, M. H., Sethy, V. H.: Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxilase inhibitor, MK 486. Neurology (Minneap) 25, 135–140 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coletti, A., Mandelli, A., Minoli, G. et al. Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and gabaergic drugs. J. Neurol. 223, 67–70 (1980). https://doi.org/10.1007/BF00313141
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00313141